skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8121

Integrated Blood Pressure Control

(151,048) Views

Editor in Chief Steven Atlas, MD

1178-7104

Review
First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination
Konstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al
Integrated Blood Pressure Control 2010, 3:163-170
01 December 2010

Review
Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
Ijlal Uddin, Shakil Aslam
Integrated Blood Pressure Control 2010, 3:155-162
16 November 2010

Review
Optimal management of hypertension in elderly patients
Maria Czarina Acelajado
Integrated Blood Pressure Control 2010, 3:145-153
11 November 2010

Review
Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control
Haroon-Ur Rashid
Integrated Blood Pressure Control 2010, 3:133-144
05 October 2010

Review
Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?
Alberto Francisco Rubio-Guerra, Hilda Vargas-Robles, Luz Maria Ramos-Brizuela, et al
Integrated Blood Pressure Control 2010, 3:125-132
29 September 2010

Review
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes
Eduardo Pimenta, Suzanne Oparil
Integrated Blood Pressure Control 2010, 3:113-123
28 September 2010

Review
Intravenous clevidipine for management of hypertension
Alma Rivera, Elsa Montoya, Joseph Varon
Integrated Blood Pressure Control 2010, 3:105-111
28 June 2010

Review
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
Jan Basile
Integrated Blood Pressure Control 2010, 3:91-104
21 June 2010

Review
Impact of telmisartan in modifying vascular risk
Jean-Philippe Baguet, Olivier Ormezzano, Gilles Barone-Rochette
Integrated Blood Pressure Control 2010, 3:81-89
15 June 2010

Review
Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals
Satoshi Morimoto, Nobuyuki Takahashi, Tatsuyori Morita, et al
Integrated Blood Pressure Control 2010, 3:73-79
03 June 2010

Review
Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness
Francesca Kum, Janaka Karalliedde
Integrated Blood Pressure Control 2010, 3:63-71
04 June 2010

Review
Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
Michel Burnier
Integrated Blood Pressure Control 2010, 3:57-62
27 May 2010

Review
Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction
Ikechi G Okpechi, Brian L Rayner
Integrated Blood Pressure Control 2010, 3:45-55
27 May 2010

Review
Evidence-based approach for managing hypertension in type 2 diabetes
Gerti Tashko, Robert A Gabbay
Integrated Blood Pressure Control 2010, 3:31-43
24 May 2010

Review
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination
Giuseppe Derosa, Sibilla AT Salvadeo
Integrated Blood Pressure Control 2010, 3:21-30
19 May 2010

Review
Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility
Vivencio Barrios, Carlos Escobar
Integrated Blood Pressure Control 2010, 3:11-19
10 May 2010

Review
De-stiffening drug therapy and blood pressure control
Michel E Safar
Integrated Blood Pressure Control 2010, 3:1-9
29 January 2010

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University